CXC chemokine ligand 13 and galectin-9 plasma levels collaboratively provide prediction of disease activity and progression-free survival in chronic lymphocytic leukemia.

Publication Year: 2023

DOI:
10.1007/s00277-023-05540-8

PMCID:
PMC10867040

PMID:
37946029

Journal Information

Full Title: Ann Hematol

Abbreviation: Ann Hematol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approvalThe study protocol was scrutinized and approved by the ethical committee of Medical Research Ethics Committee of Sohag Faculty of Medicine (number: Soh-Med-21–11-32). Consent to participateIn accordance with the Declaration of Helsinki, all subjects provided their informed consent after proper counseling before participation in the study. Conflict of interestThe authors declare no competing interests. Conflict of interest The authors declare no competing interests."

Evidence found in paper:

"Funding Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025